Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerulonephritis, IGA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06935357
What this trial is testing

Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Immunoglobulin A Nephropathy (IgAN)
Biogen 454
Large-scale testing (Phase 3)Active Not RecruitingNCT03762850
What this trial is testing

The Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy

Who this might be right for
Immunoglobulin A Nephropathy
Travere Therapeutics, Inc. 406
Post-approval studies (Phase 4)Study completedNCT01129284
What this trial is testing

Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)

Who this might be right for
Treatment Resistant Nephrotic Syndrome
Columbia University 15
Testing effectiveness (Phase 2)Looking for participantsNCT07614477
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases

Who this might be right for
Minimal Change Disease (MCD)IgA Nephropathy (IgAN)Focal Segmental Glomerulosclerosis (FSGS)
Everest Medicines (China) Co.,Ltd. 45
Very early researchNot Yet RecruitingNCT07674147
What this trial is testing

RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases

Who this might be right for
Autoimmune DiseasesSLE - Systemic Lupus ErythematosusSSc-Systemic Sclerosis+3 more
The Children's Hospital of Zhejiang University School of Medicine 30
Not applicableLooking for participantsNCT07295808
What this trial is testing

Identification and Characterisation of IgA With Nephritogenic Potential in IgA Deposition Nephropathies (Rep-IgAN)

Who this might be right for
Kidney Disease
University Hospital, Limoges 150
Testing effectiveness (Phase 2)Looking for participantsNCT07522099
What this trial is testing

Chinese Adults With Kidney Disease

Who this might be right for
Immunoglobulin A Nephropathy (IgAN)Complement 3 Glomerulopathy (C3G)IC-MPGN
ADARx Pharmaceuticals, Inc. 30
Testing effectiveness (Phase 2)WithdrawnNCT02605525
What this trial is testing

Efficacy and Safety of SM101 in the Treatment of IgA Nephropathy

Who this might be right for
Immunoglobulin A Nephropathy
Baxalta now part of Shire
Not applicableStudy completedNCT00521508
What this trial is testing

Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy

Who this might be right for
Glomerulonephritis, IGA
Centre Hospitalier Universitaire de Saint Etienne 45
Testing effectiveness (Phase 2)Looking for participantsNCT07541287
What this trial is testing

JADE101 in Participants With Immunoglobulin A Nephropathy

Who this might be right for
IgA Nephropathy
Jade Biosciences, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT02112838
What this trial is testing

Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy

Who this might be right for
IGA Nephropathy
Rigel Pharmaceuticals 76
Very early researchLooking for participantsNCT07203404
What this trial is testing

Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.

Who this might be right for
SLELNANCA Associated Vasculitis+6 more
Nanjing Bioheng Biotech Co., Ltd. 96
Testing effectiveness (Phase 2)Looking for participantsNCT07146906
What this trial is testing

Assess the Effects of Zigakibart on IgA Nephropathy.

Who this might be right for
Immunoglobulin A Nephropathy (IgAN)
Novartis Pharmaceuticals 32
Large-scale testing (Phase 3)Study completedNCT02282930
What this trial is testing

Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

Who this might be right for
Progressive IgA NephropathyProteinuria
Mayo Clinic 20
Large-scale testing (Phase 3)Looking for participantsNCT06963827
What this trial is testing

Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

Who this might be right for
Kidney Disease
Takeda 347
Not applicableLooking for participantsNCT06654596
What this trial is testing

Efficacy and Safety of Telitacicept in IgAN

Who this might be right for
IgA Nephropathy (IgAN)Kidney DiseasesTelitacicept+1 more
Ruijin Hospital 118
Large-scale testing (Phase 3)Active Not RecruitingNCT04716231
What this trial is testing

Atacicept in Subjects With IgA Nephropathy

Who this might be right for
IgA NephropathyBerger Disease
Vera Therapeutics, Inc. 376
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07553494
What this trial is testing

SLN12140 in Adult Participants With IgA Nephropathy in China

Who this might be right for
IgA Nephropathy (IgAN)
Linno Pharmaceuticals, Inc. 48
Not applicableStudy completedNCT02529722
What this trial is testing

Biomarkers for the Progression of IgA Nephropathy

Who this might be right for
IgA NephropathyGlomerular Diseases
Istanbul University 120
Not applicableNot Yet RecruitingNCT07746453
What this trial is testing

Universal STAR-T Cell Injection in Autoimmune Kidney Diseases

Who this might be right for
IgA Nephropathy (IgAN)Primary Membranous Nephropathy
Guangdong Provincial People's Hospital 24
Next Page